BAG3 Positivity as Prognostic Marker in Head and Neck Squamous Cell Carcinoma.

Cancers (Basel) · 2025 · PMC12153623 · PMID 40507324

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a possible trendno p-value reported

Patients with intermediate BAG3 scores (score 1 and score 2) had mean disease-free survival times of 23.8 and 23.2 months, respectively—both shorter than BAG3-negative patients—implying a possible trend which needs further investigation. 4.

also in 948 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.